Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells (Q43714114)

26 November 2017

Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells (English)

1 reference

26 November 2017

0 references

3

1 reference

26 November 2017

Tarui T

1

1 reference

PubMed ID

11514539

26 November 2017

Miles LA

series ordinal

2

1 reference

PubMed ID

11514539

26 November 2017

language of work or name

English

0 references

publication date

20 August 2001

1 reference

Journal of Biological Chemistry

26 November 2017

1 reference

26 November 2017

276

1 reference

26 November 2017

43

1 reference

26 November 2017

39562-39568

1 reference

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

26 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Angiostatin binds ATP synthase on the surface of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Differential regulation of airway epithelial integrins by growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

The alpha 1/beta 1 and alpha 6/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Critical residues for ligand binding in an I domain-like structure of the integrin beta1 subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

The properdin-like type I repeats of human thrombospondin contain a cell attachment site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Identification of amino acid sequences in fibrinogen gamma -chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Role of cell-surface lysines in plasminogen binding to cells: identification of .alpha.-enolase as a candidate plasminogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

The role of an enolase-related molecule in plasminogen binding to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

Changing Ligand Specificities of αvβ1 and αvβ3 Integrins by Swapping a Short Diverse Sequence of the β Subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101815200

21 January 2018

Identifiers

DOI

10.1074/JBC.M101815200

1 reference

26 November 2017

1 reference

PubMed ID

11514539